Folate Functionalized Lipid Nanoparticles for Targeted Therapy of Methicillin-Resistant <i>Staphylococcus aureus</i>

Folate Functionalized Lipid Nanoparticles for Targeted Therapy of Methicillin-Resistant <i>Staphylococcus aureus</i>

Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA), commonly called a superbug, is a highly alarming antibiotic-resistant population of <i>Staphylococcus aureus (S. aureus)</i> bacteria. Vancomycin (VAN) was first approved by the FDA in 1988, and it is still regarded a...

Full description

Bibliographic Details
Main Authors: Kushal Vanamala, Ketki Bhise, Hiram Sanchez, Razieh Kebriaei, Duy Luong, Samaresh Sau, Hosam Abdelhady, Michael J. Rybak, David Andes, Arun K. Iyer
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Pharmaceutics
Subjects:
vancomycin
liposomes
MRSA
thigh infection
antibacterial resistance
Online Access:https://www.mdpi.com/1999-4923/13/11/1791

Internet

https://www.mdpi.com/1999-4923/13/11/1791

Similar Items